Form 4 for MED MEDIFAST INC
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-20 · accession 0001628280-24-029661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-24 | 2024-06-20 | MED | BROWN JEFFREY J | Dir | A - Grant | $10.39 | +12.2K | 18.0K | +211% | +$126.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-20 | A | A | 6,596 | $0.00 | 12,379.65 | D | — | — | (F1) 6,596 restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These awards are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 20, 2025. |
| 2 | Common | Common Stock | 2024-06-20 | A | A | 5,581 | $22.66 | 17,960.65 | D | — | — | (F2) The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation for annual service as a non-employee director of the Issuer. (F3) This price per share of $22.66 is based on the 20-day moving average stock price of the Issuer's common stock as of June 18, 2024. |